Skip to content
healthcare.dev

CAMZYOS

NDC 73625-111, mavacamten, capsule, gelatin coated, from Myokardia, Inc..

Product NDC
73625-111
Status
Listed
Labeler
Myokardia, Inc.
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214998
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73625-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MAVACAMTEN2.5 mg/1

Pharmacologic classes

Cardiac Myosin Inhibitor [EPC]; Cardiac Myosin Inhibitors [MoA]

Package NDCNDC-11Package
73625-111-117362501111130 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (73625-111-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/669c936b-3ee6-4e36-8a22-79dd11b1255b

Use it

Look up 73625-111 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73625-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73625-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.